Lisa Usdan
Endocrinology, Diabetes & Metabolism · Memphis, TNNPI 1053597674
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (39.7%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Pfizer accounts for 60.7% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2021 at $720 and has fallen 52.7% since, to $340 in 2025. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in TN, where the typical reported total is $2,871.
Across 12 payments — averaging $146.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$1K
- Novo Nordisk$447
- Sequel Med Tech, LLC$147
- Neurocrine Biosciences, Inc.$87
- Lilly USA, LLC$12
Across 2,861 payments — averaging $4999.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$10.2M
- GSK$1.3M
- Modernatx, Inc.$1M
- Novo Nordisk AS$724K
- Boehringer Ingelheim$282K
- Eli Lilly$186K
- plus $586K from 10 others
What the payments were for
- Consulting fees$70040%
- Speaking & faculty fees$35020%
- Food & beverage$61735%
- Education$764%
- Gifts$201%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 3 | $1,070 |
| Novo Nordisk | 6 | $447 |
| Sequel Med Tech, LLC | 1 | $147 |
| Neurocrine Biosciences, Inc. | 1 | $87 |
| Lilly USA, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TWIIST$147
How this compares
$1,764 in reported general payments places this provider in the 40th percentile of 130 endocrinology, diabetes & metabolism providers in Tennessee.
See all endocrinology, diabetes & metabolism providers in Tennessee →
Other endocrinology, diabetes & metabolism in Memphis
- Alan CohenMemphis$1.4M
- Shimon HararyMemphis$735K
- Samuel Dagogo-JackMemphis$407K
- Aidar GosmanovMemphis$138K
- Malini GuptaMemphis$91K
- Benjamin BrannickMemphis$84K
- Pedro VelasquezMemphis$21K
- Fariha SalmanMemphis$14K
- Maher GhawjiMemphis$13K
- Yunna JiangMemphis$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.